Web Results

www.fiercepharma.com/marketing/cipher-pharmaceuticals-acquires-innocutis-holdings-licensee-of-sitavig%C2%AE-usa

Apr 13, 2015 ... Cipher Pharmaceuticals acquires INNOCUTIS Holdings, licensee of ... of INNOCUTIS Holdings LLC, the licensee of Sitavig® in the USA.

www.cipherpharma.com

Cipher Pharmaceuticals is a growing specialty company with a focus on dermatology. Our goal is to develop and acquire best-in-class skin care solutions.

scrip.pharmamedtechbi.com/companies/_id30243

Company Information. Industry; Medical Devices; Pharmaceuticals; Therapeutic Areas; Dermatology; Alias(es); Ownership; Private; Headquarters; Worldwide.

www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=131237955

Cipher Pharmaceuticals US LLC was formerly known as Innocutis Medical, LLC. The company was founded in 2010 and is based in Charleston, South Carolina.

www.crunchbase.com/organization/innocutis

Innocutis is a pharmaceutical and medical device company developing therapeutic ... Founded: 2005; Aliases: Innocutis Holdings, LLC; Contact: 843- 965-8333 ...

www.prnewswire.com/news-releases/cipher-pharmaceuticals-announces-us-commercial-entry-through-acquisition-of-innocutis-499547201.html

Apr 13, 2015 ... ... that it has acquired INNOCUTIS Holdings LLC ("INNOCUTIS"), a privately held specialty dermatology company, for US$45.5 million in cash.

www.linkedin.com/in/charles-f-jenkins-b1043732

Cipher Pharmaceuticals Inc. Previous. Innocutis Holdings, LLC,; Innocutis Medical, LLC,; Medicis. Education. University of South Carolina-Columbia. Websites.

www.postandcourier.com/business/charleston-based-innocutis-gets-m-investment/article_cb7f425a-61e2-56e3-a65a-f0dedf6582e4.html

Sep 26, 2011 ... Charleston-based dermatology drug and device firm Innocutis Holdings LLC announced Monday that it has received a $6.5 million investment ...

sitavig.com/2014/03/19/innocutis-holdings-llc-licenses-sitavig-bioalliance-pharma

Mar 19, 2014 ... Innocutis Holdings LLC is pleased to announce the licensing of Sitavig® ( ACYCLOVIR) 50mg Buccal Tablets, from BioAlliance Pharma for ...

www.theglobeandmail.com/globe-investor/investment-ideas/cipher-pharma-maps-out-its-path-to-success/article24053442

Apr 21, 2015 ... ... company Innocutis Holdings LLC for $45.5-million (U.S.) in cash, its ... Innocutis gives Cipher critical infrastructure to sell its products in the ...